| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |